Merck partners With Harvard to Develop Cancer Treatments
Posted on28 Mar 2016
Tagsacute myeloid leukemia, AML, Matthew Shair, Merck, Merck partners With Harvard to Develop Cancer Treatments
Comments0
Harvard University will partner with Merck & Co. to develop small-molecule treatments for acute myeloid leukemia (AML) and other cancers, in a... Read More